Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 1497-1500, April 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjerkvig, R.
Right arrow Articles by Deen, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjerkvig, R.
Right arrow Articles by Deen, D. F.

Cell Cycle Age Response of 9L Cells to 1,3-Bis(2-chloroethyl)-1-nitrosourea and Modification by {alpha}-Difluoromethylornithine1

Rolf Bjerkvig, Stina M. Oredsson2, Laurence J. Marton, Margareta Linden3 and Dennis F. Deen4

Brain Tumor Research Center, Department of Neurological Surgery [R. B., S. M. O., L. J. M., M. L., D. F. D.], Department of Laboratory Medicine [L. J. M.], and the Department of Radiation Oncology [D. F. D.], School of Medicine, University of California, San Francisco, California 94143

We have determined the cell cycle age response of 9L rat brain tumor cells to 1,3-bis(2-chloroethyl)-1-nitrosourea using centrifugal elutriation to obtain populations of cells enriched in G1, S, and G2-M phases. While cells in all phases of the cell cycle were killed by 20 or 40 µM 1,3-bis(2-chloroethyl)-1-nitrosourea, cells in G1 and G2-M phases were more sensitive than cells in S phase. The differential sensitivity was more pronounced at the higher dose, which will markedly alter the distribution of cells through the cell cycle. In a clinical setting, this factor could affect the efficacy of either fractionated or multimodality protocols. Treatment with {alpha}-difluoromethylornithine, a polyamine biosynthesis inhibitor, potentiated the cytotoxic effects of 20 µM 1,3-bis(2-chloroethyl)-1-nitrosourea against G1- and G2-M- but not against S-phase cells; however, at a higher dose of 1,3-bis(2-chloroethyl)-1-nitrosourea (40 µM), the cytotoxicity was potentiated for cells in all phases of the cell cycle. In {alpha}-difluoromethylornithine-treated cells, the phenomenon could be reversed by adding 1 mM putrescine 24 hr before treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. Therefore, the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity appears to be related to polyamine depletion.

1 Supported by ACS Grant RD-137, NIH Grants CA-13525 and CA-31867, and the Morris Stulsaft Foundation.

2 Recipient of travel grants from the Swedish Natural Science Research Council (R-RA 4685-100) and the Swedish Medical Research Council (B81-04R-6065-504106065).

3 Recipient of a travel grant from the Swedish Natural Science Research Council (R-RA 4818-100).

4 To whom requests for reprints should be addressed at the Brain Tumor Research Center, University of California, San Francisco, Calif. 94143.

Received 5/ 3/82. Accepted 12/16/82.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.